ArticleInvestigative ophthalmology & visual science2026
A Novel Mycovirus Reprograms the Pathogenic State of Aspergillus flavus in Keratitis.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Fungal keratitis (FK) is a major cause of corneal blindness, with substantial variability in disease severity that cannot be fully explained by host factors. This study investigated whether endogenous mycovirus infection contributes to differences in fungal pathogenicity. Methods: Fungal isolates from 38 patients with FK were analyzed by metagenomic sequencing. A novel viral RNA identified in an Aspergillus flavus isolate was characterized by sequence and phylogenetic analyses. Virus-cured strains were generated and compared with virus-infected strains using phenotypic assays, transcriptomic profiling, corneal epithelial adhesion assays, macrophage killing assays, and a murine model of FK. Results: A previously uncharacterized mycovirus, A flavus narnavirus 3, was identified within the family Narnaviridae. Viral infection impaired fungal growth, conidiation, and stress tolerance and suppressed virulence-associated traits, including sclerotia formation and aflatoxin production. A transcriptomic analysis revealed the disruption of the regulatory networks involved in development, stress responses, and metabolism. Functionally, virus-infected strains showed reduced adhesion to corneal epithelial cells and increased susceptibility to macrophage-mediated clearance. In vivo, A flavus narnavirus 3-positive strains exhibited attenuated virulence, with a lower fungal burden and reduced corneal inflammation. Conclusions: Mycovirus infection attenuates A flavus pathogenicity and modulates host responses in FK, suggesting a potential role for viral carriage in the clinical heterogeneity of disease severity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.